Verified Nov 2026
Other
·
Fort Lauderdale, Florida
·
Since 1985
Nipro Diagnostics (UK) Limited is a company headquartered in Fort Lauderdale, Florida, United States, founded in 1985. It is estimated to employ 1-50 people, with an estimated revenue band of $250-500 million. The company is privately held and serves the automotive and medical industries. Its public profile describes it as manufacturing and distributing blood glucose monitoring systems for the healthcare community. In August 2026, parent group NIPRO announced a €25 million investment in regional renal care manufacturing in Lleida, Spain.
Nipro Diagnostics (UK) Limited at a glance
Revenue
$250-500M
Est. band
Employees
1-50
Founded
1985
Headquarters
Fort Lauderdale, Florida
Import activity
249
Industries
Automotive
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
249
Named foreign suppliers
15
Top origins
Japan · South Korea · Hong Kong S.A.R. · China
Shared foreign counterparties do not establish that these companies buy from Nipro Diagnostics (UK) Limited.
What this tells a buyer
The record shows no customs data for the company, and the most recent development reported is NIPRO's August 2026 announcement of a €25 million investment in renal care manufacturing in Lleida.
The company is described as manufacturing and distributing blood glucose monitoring systems, and the record lists no certifications.
In March 2026, Development Bank of Japan Inc. announced an investment in a U.S. subsidiary of NIPRO, and in December 2025 NIPRO partnered with Diaverum on the first LiniXia installation in the UK.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Nipro Diagnostics (UK) Limited is a company headquartered in Fort Lauderdale, Florida, United States, founded in 1985. It is estimated to employ 1-50 people, with an estimated revenue band of $250-500 million. The company is privately held and serves the automotive and medical industries. Its public profile describes it as manufacturing and distributing blood glucose monitoring systems for the healthcare community. In August 2026, parent group NIPRO announced a €25 million investment in regional renal care manufacturing in Lleida, Spain.
At a glance
Attribute | Detail |
|---|---|
Founded | 1985 |
Headquarters | Fort Lauderdale, Florida |
Employees | 1-50 |
Revenue | $250-500M (estimated) |
What Nipro Diagnostics (UK) Limited makes
The company is described as manufacturing and distributing blood glucose monitoring systems, and the record lists no certifications.
Trade and customs footprint
The record shows no customs data for the company, and the most recent development reported is NIPRO's August 2026 announcement of a €25 million investment in renal care manufacturing in Lleida. US customs bill-of-lading records list 249 inbound shipments across 15 foreign suppliers, with top origins including Japan · South Korea · Hong Kong S.A.R. · China.
Latest developments
2026-08-19 — NIPRO meets Mayor of Lleida to announce €25 million Investment in Regional Renal Care Manufacturing (nipro-group.com)
2026-07-20 — Nipro Fistula needles - UKSpending (ukspending.com)
2026-03-25 — Nipro : Announcement of Investment by Development Bank of Japan Inc. in a U.S. Subsidiary of NIPRO | MarketScreener (marketscreener.com)
2025-12-17 — NIPRO Partners with Diaverum for the First LiniXia Installation in the UK (nipro-group.com)
2025-12-07 — Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others (prnewswire.com)
2025-07-16 — News | Nipro (nipro-group.com)
Facilities
Nipro Diagnostics (UK) Limited is headquartered in Fort Lauderdale, Florida. Public sources also reference these locations:
Osaka, Japan — nipro-group.com
Company details
In March 2026, Development Bank of Japan Inc. announced an investment in a U.S. subsidiary of NIPRO, and in December 2025 NIPRO partnered with Diaverum on the first LiniXia installation in the UK. Nipro Diagnostics (UK) Limited was founded in 1985, has an estimated 1-50 employees, and is headquartered in Fort Lauderdale, Florida.
Frequently asked questions
What does Nipro Diagnostics (UK) Limited do?
Nipro Diagnostics (UK) Limited is a company headquartered in Fort Lauderdale, Florida, United States, founded in 1985. It is estimated to employ 1-50 people, with an estimated revenue band of $250-500 million. The company is privately held and serves the automotive and medical industries. Its public profile describes it as manufacturing and distributing blood glucose monitoring systems for the healthcare community. In August 2026, parent group NIPRO announced a €25 million investment in regional renal care manufacturing in Lleida, Spain.
Where is Nipro Diagnostics (UK) Limited headquartered?
Nipro Diagnostics (UK) Limited is headquartered in Fort Lauderdale, Florida (2400 NW 55th Ct, Fort Lauderdale, Florida, 33309).
When was Nipro Diagnostics (UK) Limited founded?
Nipro Diagnostics (UK) Limited was founded in 1985.
How big is Nipro Diagnostics (UK) Limited?
Nipro Diagnostics (UK) Limited has an estimated 1-50 employees, with revenue in the $250-500M range (estimated).
Does Nipro Diagnostics (UK) Limited import from overseas suppliers?
US customs bill-of-lading records show 249 inbound shipments for Nipro Diagnostics (UK) Limited, with top origins including Japan · South Korea · Hong Kong S.A.R. · China.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.